Advertisement
Home 2016 July

Monthly Archives: July 2016

Postpartum readmission rates rose from 2004 to 2011

Postpartum Readmission Within Six Weeks of Delivery on the Rise

0
Readmission more likely among black, publically insured patients with comorbidities
Patient variables seem not to be associated with hemoglobin A1c targets

Patient Variables Not Linked to Hemoglobin A1c Targets

0
Targets not tied to demographics, medical history, physical and mental health, health service use
A metabolomics signature can predict the transition from gestational diabetes mellitus to type 2 diabetes

Metabolomics Signature Can Predict GDM to T2DM Transition

0
Metabolomics with baseline fasting plasma could predict transition from gestational diabetes to T2DM
Severe nonproliferative diabetic retinopathy or proliferative diabetic retinopathy

Diabetic Retinopathy Independently Tied to Depression

0
Severe nonproliferative/proliferative diabetic retinopathy linked to greater depressive symptoms
A genetic test may one day be able to predict the risk for Alzheimer's disease in young adults

Risk Score Could Help ID Alzheimer’s Risk in Young Adults

0
Score also associated with worse memory, clinical progression in older adults
Toys help spread the flu and other viruses because germs can survive on plastic surfaces for 24 hours or more

Toys in Waiting Room May Be Source of Infection

0
Germs can survive on plastic surfaces for 24 hours or more
Pharmacists often encounter fees imposed by prescription drug "middlemen" that adversely impact both pharmacies and patients and distort medication costs and reimbursement rates

Pharmacists Report Hidden Fees That Distort Prescription Costs

0
Direct and indirect remuneration fees, copay clawback fees skew cost of prescription meds
Compared with 2012

Docs Tending Away From Post-Prostatectomy Adjuvant RT

0
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 versus 2012
Neratinib and veliparib-carboplatin appear to be effective in women with specific subtypes of breast cancer

Neratinib Active in HER2-Positive, HR-Negative Breast Cancer

0
And higher pathologic complete response for veliparib-carboplatin in triple-negative breast cancer
For men with metastatic prostate cancer

DNA-Repair Gene Mutations ID’d in Metastatic Prostate Cancer

0
Prevalence of 11.8 percent for germline DNA-repair gene mutations presumed to be deleterious